Skip to content

Comparison of triamcinolone and ketorolac in patients with knee osteoarthritis

The effect of intra articular injection of triamcinolone in comparison with ketorolac on pain and function of patients with knee osteoarthritis, single blind clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017041633000N2
Enrollment
40
Registered
2017-04-26
Start date
2016-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis (Gonarthrosis). Gonarthrosis [arthrosis of knee]

Interventions

Intervention 1: Intervention group 1: triamcinolone, knee intraarticular injection, 40 mg 1 time. Intervention 2: Intervention group 2: ketorolac, knee intraarticuar injection, 30mg, 1 times.
Treatment - Drugs
Intervention group 1: triamcinolone, knee intraarticular injection, 40 mg 1 time
Intervention group 2: ketorolac, knee intraarticuar injection, 30mg, 1 times

Sponsors

Physical Medicine and Rehabilitation Department of Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: arthralgia since the past 3 months; radiologic evidence of articular damage (grade 2,3 of Kellgren-Lawrence scale) based on knee OA criteria of ACR and age between 45-75 years. Exclusion criteria: systemic diseases such as rheumatoid arthritis (RA), any history of intera articular injection, knee surgery or physiotherapy in the last 3 months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Knee pain. Timepoint: before intervention,1 months & 3 months after intervention. Method of measurement: WOMAC questionnaire.;Joint Stiffness. Timepoint: before intervention, 1 months & 3 months after intervention. Method of measurement: WOMAC questionnaire.;Function. Timepoint: before intervention,1 months & 3 months after intervention. Method of measurement: WOMAC questionnaire.;The maximum distance of walking. Timepoint: before intervention, 1 months & 3 months after intervention. Method of measurement: Lequesne Index.;Activity of daily living. Timepoint: before intervention, 1 months & 3 months after intervention. Method of measurement: Lequesne Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Adili

Shahid Beheshti Univeraity of Medical Sciences

mahsaadili@gmail.com+98 21 6606 6490

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026